about
Reemergence of Splenectomy for ITP Second-line Treatment?Mu opioid receptor expression is increased in inflammatory bowel diseases: implications for homeostatic intestinal inflammation.Pre-operative management is associated with low rate of post-operative morbidity in penetrating Crohn's disease.Liver resection in management of post-cholecystectomy biliary injury: a case series.Pancreas-preserving management in reinterventions for severe pancreatic fistula after pancreatoduodenectomy: a systematic review.Postoperative Complications after Ileocecal Resection in Crohn's Disease: A Prospective Study From the REMIND Group.Post-operative recurrence of Crohn's disease after definitive stoma: an underestimated risk.Atrial embolism caused by portal vein embolization: Treatment by percutaneous withdrawal and stentingPersistent perineal sinus after abdominoperineal resection.Pancreatic serous cystadenoma with compression of the main pancreatic duct: an unusual entity.Life-threatening postoperative pancreatic fistula (grade C) after pancreaticoduodenectomy: incidence, prognosis, and risk factors.Emergency major abdominal surgery in patients over 85 years of age.Experience of gemcitabine plus oxaliplatin chemotherapy in patients with advanced biliary tract carcinoma.Efficacy of sacral nerve stimulation for poor functional results of J-pouch ileoanal anastomosis.Anti-TNF Therapy Is Associated With an Increased Risk of Postoperative Morbidity After Surgery for Ileocolonic Crohn Disease: Results of a Prospective Nationwide Cohort.Celiac axis and superior mesenteric artery: danger zone for left nephrectomy.Tumor size of hepatocellular carcinoma in noncirrhotic liver: a controversial predictive factor for outcome after resection.Sacral nerve stimulation can alleviate symptoms of bowel dysfunction after colorectal resections.Gallium nitrate induces fibrinogen flocculation: an explanation for its hemostatic effect?Conservative management of severe caustic injuries during acute phase leads to superior long-term nutritional and quality of life (QoL) outcome.Cost-effectiveness of New Surgical Treatments for Hemorrhoidal Disease: A Multicentre Randomized Controlled Trial Comparing Transanal Doppler-guided Hemorrhoidal Artery Ligation With Mucopexy and Circular Stapled Hemorrhoidopexy.Practice patterns in complex ventral hernia repair and place of biological grafts: a national survey among French digestive academic surgeons.Ileal or Anastomotic Location of Lesions Does Not Impact Rate of Postoperative Recurrence in Crohn's Disease Patients Classified i2 on the Rutgeerts Score.Previous Exposure to Multiple Anti-TNF Is Associated with Decreased Efficiency in Preventing Postoperative Crohn's Disease Recurrence.Gastrocele complicates the course of non-operated severe caustic injuries: operative strategies.Giant colon diverticulum.Un vrai micmac!Mo1900 Combination Therapy With Infliximab and Methotrexate Does Not Improve Crohn's Disease Outcome and Infliximab Tolerance Compared to Infliximab Therapy AloneMo1898 Continuation or Switch to Another Anti-TNFα After Intestinal Resection in Crohn's Disease Patients Previously Exposed to Anti-TNFα?Mo1899 Evaluation and Long-Term Benefit of Deep Remission in Crohn's Disease Patients Treated With InfliximabTu1881 HLA B27 Transgenic Rat: A New Animal Model of Postsurgical Ileitis in Inflammatory Bowel Disease[Acute primary intestinal intussusception in an adult diagnosed by ultrasonography][Blunt pancreatic fractures][Cytomegalovirus ileitis: a rare cause of digestive hemorrhage][Hemorrhagic digestive metastases from testicular choriocarcinoma][Adenocarcinoma of the gastric stump]Purpura fulminans in an asplenic patientEndovascular versus open revascularization for chronic mesenteric ischemia: a comparative study[Metachronous cancer of common bile duct after resection of an intrahepatic cholangiocarcinoma]The conservative management of severe caustic gastric injuries
P50
Q33436010-0E1DBE4A-5650-40F8-90A7-DEBE98A46996Q35760524-35F823DC-305B-440A-9050-5B895332DB16Q37760242-B5EE1E04-0F34-4352-9CC5-09771A9F511BQ38061344-F8509FF6-3477-4503-B600-454BEFE0ADEBQ38639362-05E95C4C-8E41-45AC-9A3B-CE4DA1D26F00Q39106087-555A08F1-059E-4F2F-94C3-1D96971A39B9Q39155206-7C104824-EE5D-4FC0-868F-3E4DA31310F4Q39478029-092053B6-25D4-4AE8-AAEB-143FA8B710A1Q40070784-BDF091B3-5B8F-4CC4-B381-4E74F6C4FD7CQ41852023-EFF36D18-BFE9-422A-8912-C910F49D9814Q42000754-0C8C5C2C-613E-4151-AF88-1761E7D4F5FDQ42024633-D835247D-F697-4607-82C6-3DF2E56EBF5EQ43020287-E889565D-0906-4BED-B2AB-0E8773953592Q43362758-8478A9C0-0CA3-46A8-8720-FC5DD2B51D9AQ47210271-BC78FBE5-BEF8-4CC2-92CD-958EBD106084Q47263021-8FAA3D00-927A-438A-AC99-FB70DE9F91BEQ47293605-1EED33A3-171B-448A-A67F-CBD2C1764B68Q47441425-6D9B120A-FFC2-4ED4-B05D-E2DD587E7A66Q47743972-01F4E055-4073-4534-9D11-E2A5133F6D88Q47877528-1FB148D5-1492-4D99-AAB1-3388FED5BD9FQ48671363-05AAD77E-417F-4777-9295-2C47B0C6D820Q50737049-A04CF54E-EF04-4221-9661-D0A8B015B98BQ50786111-202EE974-14FB-40E5-8946-4C13B34236DDQ51541150-82FDC106-FE66-4E08-8E7E-AD54D5331BE8Q51768769-E2CFE506-D4D0-438F-B699-C4F56F94C857Q53418726-658D86F9-0593-464E-9CE4-C87F0DD16918Q56978346-C7F6ED6A-C824-49CC-9821-7EC2A35460B0Q62660118-FDAA25CC-6ADE-4D52-AFB1-56E7D7607C49Q62660119-74FD4BDE-24B8-4060-ABA5-6E51BCC0B445Q62660122-656D2F09-54D6-4B7B-9AD1-30AE5DC29C77Q62660124-3F64C3C7-1EDB-4B81-A7D7-A76CE8622D65Q73830358-93A40DBC-6DAC-42C3-A687-4445D494D452Q74182365-9D27C9FE-5B66-456D-8FA3-70383D0B2909Q77116167-DC8AC6F3-CCFD-45D9-B08A-31AFB398B4A3Q78018841-359C2671-A361-47A5-8E76-7E36BB788A71Q79166003-5D613887-3D90-42D7-9315-ABB83D4BA9FAQ81356053-74AD5FD2-7C16-4C43-A0FD-E240E567A09CQ81513394-E6A764C0-1CFB-4CE6-BD99-0103798DA93AQ82493420-24D5208D-6596-4F5D-81B1-2821A63FE5B9Q83809933-EDD1863E-0E1F-4339-AC34-0B4186FE5166
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Philippe Zerbib
@ast
Philippe Zerbib
@en
Philippe Zerbib
@es
Philippe Zerbib
@nl
type
label
Philippe Zerbib
@ast
Philippe Zerbib
@en
Philippe Zerbib
@es
Philippe Zerbib
@nl
prefLabel
Philippe Zerbib
@ast
Philippe Zerbib
@en
Philippe Zerbib
@es
Philippe Zerbib
@nl
P106
P31
P496
0000-0002-6466-0716